Venture Capital

With a major acquisition and a volatile stock, all eyes are on ServiceNow's Jan 28 results to prove its AI strategy is delivering real financial growth.

The market research tech firm secures a strategic investment from TA Associates to scale its AI-powered platform and redefine data quality standards.

The world's best-selling author joins the global talent agency in a move set to expand his literary brand and amplify his philanthropic mission worldwide.

Scientists unveil a DARPA-funded biofilm that may expel 98% of ingested microplastics, offering a new defense in the fight for human health.

New research confirms a soil inoculant improves nutrient retention and crop health, offering farmers a tool for both profit and sustainability.

After a multi-year slump, investors poured nearly $14 billion into cybersecurity in 2025, driven by AI risks and the relentless growth of cybercrime.

A biotech firm's promising concussion therapy, backed by NFL's Alex Smith, shows an 85% responder rate and now seeks public funding for its final push.

With a new CEO known for scaling tech giants, Planview is doubling down on its AI-first platform to dominate the strategic portfolio management market.

Associated Food Stores is deploying FORM's advanced retail tech, giving its 500 independent members new tools to optimize shelves and challenge major chains.

The 2026 auto show reveals a market in flux. Hybrids are back, EVs adapt post-rebate, and the hunt for affordable cars intensifies. What's next?

The global asset manager appoints Kikuo Shirose to lead its Japan office, signaling a deep push into the nation's booming real assets and alternatives market.

A Boston biotech, armed with $62M and a new name, unveils a plan to build a universal model of the cell, aiming to predict and control its behavior.

Backed by Frazier Healthcare Partners, the new CareTria aims to slash patient wait times for medication with a powerful, end-to-end technology platform.

Pharma giant Lilly and AI biotech BigHat are teaming up to solve a critical flaw in AI drug discovery, aiming to unlock a new generation of therapies.

Palisade Bio's PALI-2108, a drug targeting IBD at its source, secures a key investment, offering hope for a new era of treatment with fewer side effects.

Formerly Pure Harvest, Mixie Technologies acquires a stake in digital twin firm HoloTwin, signaling a major strategic shift into AI and platform solutions.

Health tech firm IMVARIA, maker of an FDA-authorized AI for lung disease, has secured strategic funding from InHealth Ventures and Labcorp to expand its reach.

A new partnership gives NWS forecasters unprecedented views into weather blind spots, boosting warning capabilities for 130 million Americans.

Fresh off its 'Fierce 15' win, Recludix Pharma and its billion-dollar Sanofi pact take the spotlight with a novel oral drug for inflammatory diseases.

A new partnership aims to use advanced nuclear reactors to produce life-saving medical isotopes on U.S. soil, tackling a critical national vulnerability.